We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Shires Income plc (SHRS) Ordinary 50p Shares

Sell:225.00p Buy:228.00p 0 Change: No change
Market closed Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:225.00p
Buy:228.00p
Change: No change
Market closed Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:225.00p
Buy:228.00p
Change: No change
Market closed Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

The investment objective is to provide shareholders with a high level of income, together with the potential for growth of both income and capital from a diversified portfolio substantially invested in UK equities but also in preference shares, convertibles and fixed income securities
Sector Weight
Financial Services 22.08%
Energy 17.01%
Utilities 9.75%
Healthcare 9.69%
Consumer Cyclical 8.90%
Industrials 7.24%
Basic Materials 5.57%
Technology 3.57%
Real Estate 3.29%
Consumer Defensive 3.05%
Country Weight
United Kingdom 79.54%
France 4.14%
United States 3.17%
Germany 3.04%
Italy 1.52%
Denmark 1.12%
Netherlands 1.02%
Australia 0.03%
Canada 0.03%

Fee Structure

Management fee is 0.45% p.a. up to GBP100m and 0.40% p.a. over GBP100m of the net assets, calculated monthly and paid quarterly. Contract is terminable on notice period of six months.

Dividend Policy

The Company aims for a high and growing dividend level. Dividends are payable quarterly in October, January, April and July.

ASSET SPLIT

Total number of holdings: 79.

Trust Manager

Iain Pyle

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Robert TalbutChairman, Simon White, Helen Sinclair, Robin Archibald, Jane Pearce

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.